Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia

Gozzetti, A; Candi, V; Brambilla, CZ; Papini, G; Fabbri, A; Bocchia, M

Gozzetti, A (reprint author), Univ Siena, Azienda Osped Univ Senese, Dept Hematol, Policlin S Maria Scotte, Viale Bracci 16, I-53100 Siena, Italy.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017; 17 (8): 1040

Abstract

Abnormality of the B-cell receptor (BCR) signaling is correlated to origin of many B-cell malignancies. Bruton's tyrosine kinase (BTK), is described a......

Full Text Link